Cite
HARVARD Citation
Van Hees, S. et al. (2018). Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes. Alimentary pharmacology & therapeutics. 47 (8), pp. 1170-1180. [Online].